Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design

Data Supplement

Files in this Data Supplement:

• Supplemental Table -

  Supplemental Table 1 - Clinically usable compounds and in vitro to in vivo translation inhibition calculations (I1/IC50 and I2/IC50)

  References